Advertisement

Topics

Solace Lifesciences Company Profile

10:52 EDT 20th June 2018 | BioPortfolio

Solace Lifesciences, the creators of NuCalm, is a pioneer in the fields of applied neuropsychobiology and bioinformatics. Founded in 2002, the company is dedicated to improving the human experience® through scientific exploration and best-in-class clinical implementations of patient-focused solutions. Healthcare professionals rely on Solace Lifesciences to improve clinical outcomes and increase patient satisfaction.


News Articles [87 Associated News Articles listed on BioPortfolio]

Edwards Lifesciences Corp (EW) VP Sells $762,300.00 in Stock

Edwards Lifesciences Corp VP Larry L. Wood sold 6,300 shares of Edwards Lifesciences stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $121.00, for a tota...

Insider Selling: Edwards Lifesciences Corp (EW) CFO Sells 25,000 Shares of Stock

Edwards Lifesciences Corp CFO Scott B. Ullem sold 25,000 shares of Edwards Lifesciences stock in a transaction dated Wednesday, April 4th. The stock was sold at an average price of $137.17, for a tota...

Head-To-Head Contrast: Edwards Lifesciences

Edwards Lifesciences and Wright Medical Group are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earni...

Edwards Lifesciences Corp. Earnings Rise In Q4

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) announced a profit for its fourth quarter that rose compared to the same period last year.The company said its bottom line totaled $203.1 mil...

$400M share repurchasing deal reached by Edwards Lifesciences

An agreement to buy back $400 million in common shares was reached by Edwards Lifesciences, which will receive about 2.5 mill -More- 

ReShape Lifesciences announces cost-reduction, integration efforts

ReShape Lifesciences announced plans to implement an operating expenses reduction of about 25%, bringing its monthly expendit -More- 

Edwards Lifesciences Corp. Q1 adjusted earnings Beat Estimates

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) reported a profit for first quarter that declined from last year.The company's earnings totaled $206.6 million, or $0.96 per share. This comp...

The Importance of Communications in LifeSciences

In this episode of PharmaTelevision News Review Fintan Walton talks to Sue Charles & Nicole Yost of College Hill, Sharon Valdettaro from Roche & Katja Toon from AstraZeneca about the importance of co...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Fluconazole [Claris Lifesciences Inc.]

Fluconazole Injection For Intravenous Use OnlyRx only

Metronidazole [Claris Lifesciences Inc.]

Metronidazole Injection, USP

Ampicillin [Claris Lifesciences, Inc.]

Ampicillin for Injection, USP for Intramuscular or Intravenous Injection Rx only

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Goal-Directed Fluid Resuscitation Protocol Based on Arterial Waveform Analysis of Major Burn Patients in a Mass Burn Casualty.

Adequate fluid titration during the initial resuscitation period of major burn patients is crucial. This study aimed to evaluate the feasibility and efficacy of a goal-directed fluid resuscitation pro...

Randomized trial of the Carpentier-Edwards supra-annular prosthesis versus the Medtronic Mosaic aortic prosthesis: 10-year results.

We performed a prospective randomized study comparing the clinical performance of the Carpentier-Edwards supra-annular valve (CE-SAV) (Edwards Lifesciences, Irvine, CA, USA) and the newer Mosaic (Medt...

Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis.

Current retrospective evidence suggests similar clinical and superior hemodynamic outcomes of the Sorin Freedom Solo stentless aortic valve (SFS) (LivaNova PLC, London, UK) compared to the Carpentier ...

The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.

We report the first successful valve-in-valve (ViV) implantation into a failed Edwards Biophysio surgical prosthesis (Edwards Lifesciences, Irvine, CA) and also the first use of the J-Valve system (Ji...

Clinical Trials [20 Associated Clinical Trials listed on BioPortfolio]

Solace Stress Urinary inContinence Control Efficacy and Safety Study

The SUCCESS Trial is designed to determine whether the Solace Bladder Control System is safe and effective for the treatment of Stress Urinary Incontinence (SUI) in adult females.

Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population

To evaluate the safety and effectiveness of the SAPIEN XT (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic seve...

Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) in the Chinese Population

To evaluate the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic sever...

Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Replacement (TMVR) Early Feasibility Study

Early feasibility study to evaluate the safety and function of the Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve

Hemodynamic Optimization During Major Abdominal Surgery

In this prospective observational study investigators aim to search any relationship between the venous to arterial carbon dioxide gap and the time of percentage to adherence too a stroke ...

Companies [32 Associated Companies listed on BioPortfolio]

Solace Lifesciences

Solace Lifesciences, the creators of NuCalm, is a pioneer in the fields of applied neuropsychobiology and bioinformatics. Founded in 2002, the company is dedicated to improving th...

Solace Lifesciences, Inc.

Founded in 2002, Solace Lifesciences, Inc. is a privately held Wilmington, Delaware based company. The neuroscience company is a leading innovator in solving one of the most profo...

Solace Therapeutics, Inc.

Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office based treatments for common bladder disorders, such as stress urinary incontinence (SUI), ov...

Solace Pharmaceuticals

Solace Pharmaceuticals discovers and develops innovative treatments for pain. Solace's research and development programs are focused on exploiting novel biological understanding of disease targets th...

Solace Therapeutics Inc.

Solace Therapeutics is dedicated to developing innovative, non-surgical and clinically effective devices that address unmet needs in lower urinary tract symptoms (LUTS). Our initi...

More Information about "Solace Lifesciences" on BioPortfolio

We have published hundreds of Solace Lifesciences news stories on BioPortfolio along with dozens of Solace Lifesciences Clinical Trials and PubMed Articles about Solace Lifesciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Solace Lifesciences Companies in our database. You can also find out about relevant Solace Lifesciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record